Labiotech.eu

novo nordisk holding impact antimicrobial resistance slides

News and Trends 22 Jan 2019

MinervaX Latest Beneficiary of Novo’s Antimicrobial Resistance Fund

The Novo Holdings REPAIR Impact Fund, launched to fight antimicrobial resistance, has invested €4.4M in the Danish company MinervaX to help fund the phase I trial of a vaccine that could protect newborn babies from streptococcal infections. The Novo Holdings REPAIR Impact Fund aims to combat the growing menace of pathogens resistant to antimicrobial drugs, such as […]

January 22, 2019 - 2 minutesmins - By Jonathan Smith

More News! 21 Jan 2019

Danish Biotech Turns Bacteria into Fermentation Workaholics

The Danish biotech Enduro Genetics has shown it can improve the yield of fermentation by engineering bacteria to become ‘addicted’ to being productive. Fermentation vats full of bacteria or yeast are the workhorses for industries such as the pharmaceutical and chemical industry. They are used to mass-produce products including detergents, drugs and biofuels. The cells […]

January 21, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 18 Jan 2019

Biotech Partnership Raises €7.5M to Recycle Plastics With Enzymes

The French biotechs Carbios and Toulouse White Biotechnology have been awarded €7.5M to industrialize their plastic recycling programme, which uses enzymes to break down waste. The funding comes from the public initiative Investments for the Future Program, which is aimed to foster innovation in French industries. The €7.5M is to be paid in installments over […]

January 18, 2019 - 2 minutesmins - By Jonathan Smith

Startup Scout 18 Jan 2019

This Biotech Turns Rejected Organs Into Drug Testing Models

Engitix, a spinout from University College London, makes accurate disease models from human tissue that include the extracellular matrix from outside of the cells, an often overlooked but essential factor in the way cells behave inside our bodies. Mission: To make disease models in the lab that include the extracellular matrix, making them more […]

January 18, 2019 - 4 minutesmins - By Jonathan Smith

News and Trends 17 Jan 2019

Scientists Create Prosthetic Ears Using 3D Bioprinting

Swiss researchers are developing cellulose-based materials for 3D bioprinting, which could lead to implants such as prosthetic ears. 3D-printed implants have big potential in the field of regenerative medicine. Although still at an early stage, this technology is enabling the development of customized prosthetics, such as skin and joint cartilage. One big focus in […]

January 17, 2019 - 3 minutesmins - By Jonathan Smith

Interview 16 Jan 2019

The Coming of Age of Biotechnology

Since its beginnings in the 1970s, the biotech industry has grown massively and made huge advances. At our recent Labiotech Refresh in London, Tim Haines, Managing Partner at the life science VC Abingworth, shared his views on how biotechnology has finally come of age. Haines knows the biotech industry well. After leading and helping sell […]

January 16, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

sanofi biomunex cancer therapy bispecific antibodies 1

News and Trends 15 Jan 2019

Sanofi Obtains License for French Company’s Antibody Engineering Platform

Sanofi has signed a licensing deal with French biotech Biomunex, whose antibody technology has the potential to develop new immunotherapy treatments for cancer and infectious diseases. Sanofi will give Biomunex an upfront payment, along with further installments upon achieving key development milestones. The amounts have not been disclosed. Biomunex is able to make a wide variety […]

January 15, 2019 - 2 minutesmins - By Jonathan Smith

picometrics technologies Huntingtons disease neuron

News and Trends 15 Jan 2019

Huntington’s Could Be Diagnosed in Five Minutes With This Lab-on-a-Chip

Using a lab-on-a-chip device, Swiss scientists have found a way to diagnose the neurodegenerative condition Huntington’s disease from DNA in the blood in just five minutes, rather than the five hours currently required. When carrying out the diagnosis of Huntington’s patients, the patient’s DNA is typically extracted from white blood cells. Regions of the […]

January 15, 2019 - 2 minutesmins - By Jonathan Smith

More News! 14 Jan 2019

Inhaled Lung Disease Treatment Encounters Mixed Results in Phase II Trial

An inhaled drug from British company Verona Pharma has failed to significantly improve lung function in patients with the lung disease chronic obstructive pulmonary disease, though it did produce some benefits. The 79 patients in the phase II trial suffered from chronic obstructive pulmonary disease, a condition where inflammation in the lungs restricts the airways […]

January 14, 2019 - 3 minutesmins - By Jonathan Smith

Bioplastics feature update biopolymer header

In Depth 14 Jan 2019

Life in Bioplastic, it’s More Fantastic

Plastic is the staple material of modern life, and a sustainable future will need bioplastics. What is biotech doing to make this happen? “What do you include in bioplastics? Because bioplastics is a very large word,” commented Emmanuel Maille, formerly Director of Strategy and Development at French chemical company Carbios, which focuses on developing biobased […]

January 14, 2019 - 10 minutesmins - By Denise Neves Gameiro

News and Trends 14 Jan 2019

Update: French Biotech Considers Takeover After Failed Leukemia Drug Trial

Update (14/01/2019): An anonymous French company on Euronext has made an offer to take over Hybrigenics Pharma. This takeover bid could be good news for Hybrigenics, which has been planning to dissolve the company after the failed Phase II trial of its only candidate, a treatment for acute myeloid leukemia. The financial details of the offer […]

January 14, 2019 - 2 minutesmins - By Jonathan Smith

Startup Scout 11 Jan 2019

This Company Automates Cancer Research from Bench to Bar Charts

In the academic city of Oxford, UK, the company Arctoris is working to make life easier for cancer lab researchers, letting them ‘order’ experiments online using its robotic facilities and data analysis tools. Mission: To cut down researchers’ workloads by automating cellular, molecular, and data analysis techniques in cancer research. As any molecular biologist will […]

January 11, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

MinervaX Latest Beneficiary of Novo’s Antimicrobial Resistance Fund

Danish Biotech Turns Bacteria into Fermentation Workaholics

Biotech Partnership Raises €7.5M to Recycle Plastics With Enzymes

This Biotech Turns Rejected Organs Into Drug Testing Models

Scientists Create Prosthetic Ears Using 3D Bioprinting

The Coming of Age of Biotechnology

Sanofi Obtains License for French Company’s Antibody Engineering Platform

Huntington’s Could Be Diagnosed in Five Minutes With This Lab-on-a-Chip

Inhaled Lung Disease Treatment Encounters Mixed Results in Phase II Trial

Life in Bioplastic, it’s More Fantastic

Update: French Biotech Considers Takeover After Failed Leukemia Drug Trial

This Company Automates Cancer Research from Bench to Bar Charts

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!